Dishman Pharmaceuticals & Chemicals, a leading drug manufacturer, has reported decent 22% growth in its consolidated net profit for the year ended March 31, 2009.

In a filing to Bombay Stock Exchange, the company said that it has recorded consolidated net profit of Rs 146 crore during the period under review, as compared to Rs 119 crore in the same period ended March  2008.

Total income of the company for the same period surged to Rs 1,067 crore from Rs 804 crore in the previous year.

Further, the company’s board has declared a dividend of Rs 1 per share on the face value of Rs 2 per share for the financial year 2008-2009.

Stock of Dishman Pharmaceuticals & Chemicals marked its closure at Rs 174, after making a gain of 19.99% on Bombay Stock Exchange (BSE). The total volume of shares traded on BSE was 595,225.